- Conditions: Dyskinesia; Levodopa Induced Dyskinesia; Parkinson's Disease
Intervention: Drug: ADS-5102 (extended release amantadine HCl)
Sponsors: Adamas Pharmaceuticals, Inc.; Adamas Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Condition: Influenza
Interventions: Drug: Amantadine, Ribavirin, Oseltamivir; Drug: Oseltamivir
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Condition: Parkinson's Disease
Interventions: Drug: Amantadine; Drug: Placebo
Sponsors: Rush University Medical Center; Rush University Medical Center; Michael J. Fox Foundation for Parkinson's Research
Recruiting - verified July 2011 - Conditions: Brain Injury; Aggression
Interventions: Drug: Amantadine Hydrochloride; Drug: Placebo
Sponsors: Carolinas Healthcare System; Carolinas Healthcare System; Indiana University; University of Washington; The Institute for Rehabilitation and Research; Spaulding Rehabilitation Hospital; Ohio State University; Mount Sinai School of Medicine
Recruiting - verified February 2012
 |
Amantadine Clinical Trials |
